|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred revenue and lease intangibles, net | |||||
| Other non-cash amortization | |||||
| (Reversal of) allowance on loans receivable and investments, net | |||||
| Stock-based compensation | |||||
| Straight-lining of rental income | |||||
| Loss (gain) on extinguishment of debt, net | |||||
| Gain on real estate dispositions | |||||
| Gain on real estate loan investments | |||||
| Income tax benefit | |||||
| Income from unconsolidated entities | |||||
| Gain on foreclosure of real estate | |||||
| Distributions from unconsolidated entities | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in other assets | |||||
| (Decrease) increase in accrued interest payable | |||||
| Increase (decrease) in accounts payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Net investment in real estate property | |||||
| Investment in loans receivable | |||||
| Proceeds from real estate disposals | |||||
| Proceeds from loans receivable | |||||
| Proceeds from sale of interest in unconsolidated entities | |||||
| Net cash assumed in foreclosure of real estate | |||||
| Development project expenditures | |||||
| Capital expenditures | |||||
| Distributions from unconsolidated entities | |||||
| Investment in unconsolidated entities | |||||
| Insurance proceeds for property damage claims | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net change in borrowings under revolving credit facilities | |||||
| Net change in borrowings under commercial paper program | |||||
| Proceeds from debt | |||||
| Repayment of debt | |||||
| Purchase of noncontrolling interests | |||||
| Payment of deferred financing costs | |||||
| Issuance of common stock, net | |||||
| Cash distribution to common stockholders | |||||
| Cash distribution to redeemable OP unitholders | |||||
| Cash issued for redemption of OP Units | |||||
| Contributions from noncontrolling interests | |||||
| Distributions to noncontrolling interests | |||||
| Proceeds from stock option exercises | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Effect of foreign currency translation | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid excluding capitalized interest | |||||
| Capitalized interest | |||||
| Supplemental schedule of non-cash activities: | |||||
| Assets acquired and liabilities assumed from acquisitions and other: | |||||
| Real estate investments | |||||
| Other assets | |||||
| Debt | |||||
| Other liabilities | |||||
| Deferred income tax liability | |||||
| Noncontrolling interests | |||||
| Equity issued | |||||
| Settlement of loan receivable | |||||
| Assumption of debt related to real estate owned | |||||
| Equity issued for redemption of OP Units | |||||
| Investment in unconsolidated entities |
Loading...